Jin uses his strong scientific background to assist clients with a variety of patent and other intellectual property needs. With a Ph.D. in organic chemistry as well as prior experience as a research scientist for pharmaceutical companies, he possesses a comprehensive knowledge of the science behind his clients’ innovations.
Jin has significant experience working closely with scientists to determine the patentability of bio-conjugates and relevant components, including linkers and payloads. He advises clients on the patentability of subject matter, including compositions for oral hygiene, methods for enhancing blood vessels in angiography images, as well as compositions and methods for food preservation.
Jin has led numerous IP due diligence investigations for organizations, including biotechnology and biopharmaceutical companies, in multimillion-dollar mergers and acquisition transactions. Jin has experience analyzing all relevant drug substance facts, including route of synthesis, formulation, polymorphs and treatment regimen.
He handles all stages of the patent process, from planning the appropriate filing strategy to prosecuting patent infringement issues. Jin has rendered legal opinions on patent infringement and validity relating to cytotoxic molecules, synthesis and methods of treating various types of cancer. He has prosecuted various patent applications related to therapeutic molecules, chemical compositions, biotech processes, fermentation and diet supplements.
- U.S. Pat. No. 8,735,414, 7,973,069, 7,781,478, 7,772,271, co-inventor with G. Karp, et al.
Before Fox Rothschild
Prior to joining Fox Rothschild, Jin worked as a patent attorney for a nationwide law firm, as well as a patent agent. In this capacity, Jin advised clients on intellectual property issues and handled a variety of their patent needs in regards to compositions for oral hygiene, methods for enhancing blood vessels in angiography images, as well as therapeutic molecules, chemical compositions, biotech processes, fermentation and diet supplements.
Before entering the legal field, Jin worked as a research scientist for PTC Therapeutics and Johnson & Johnson Pharmaceutical R&D, LLC, developing and researching high potency compounds and chemical genus and subgenus among others.
Jin received his Ph.D. in organic chemistry from the University of Maryland at College Park before serving as a postdoctoral associate in the Duke University Department of Chemistry. As a postdoctoral associate, Jin synthesized demethylasterriquinones in the discovery of anti-diabetic agents.